| 000 | 01681 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514184617.0 | ||
| 264 | 0 | _c20041025 | |
| 008 | 200410s 0 0 eng d | ||
| 022 | _a0960-8931 | ||
| 024 | 7 |
_a10.1097/00008390-200402000-00005 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aNikkola, Johanna | |
| 245 | 0 | 0 |
_aIntegrin chains beta1 and alphav as prognostic factors in human metastatic melanoma. _h[electronic resource] |
| 260 |
_bMelanoma research _cFeb 2004 |
||
| 300 |
_a29-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunoenzyme Techniques |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aIntegrin alphaV _xmetabolism |
| 650 | 0 | 4 |
_aIntegrin beta1 _xmetabolism |
| 650 | 0 | 4 |
_aKi-67 Antigen _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMelanoma _xmetabolism |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aSkin Neoplasms _xmetabolism |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aVihinen, Pia | |
| 700 | 1 | _aVlaykova, Tatyana | |
| 700 | 1 | _aHahka-Kemppinen, Marjo | |
| 700 | 1 | _aHeino, Jyrki | |
| 700 | 1 | _aPyrhönen, Seppo | |
| 773 | 0 |
_tMelanoma research _gvol. 14 _gno. 1 _gp. 29-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00008390-200402000-00005 _zAvailable from publisher's website |
| 999 |
_c14804075 _d14804075 |
||